The Asian ceramic biomaterial market is driven by unique properties of ceramic biomaterials such as biocompatibility, high resistance to corrosion and compression, and low electrical and thermal conductivities, making them highly suitable for implants, which makes them suitable for usage in various medical applications such as orthopedic, cardiovascular, wound healing, and dentistry. The market was valued at $2.3 million in 2013 and is estimated to be $5.83 million by 2018, at a CAGR of 20.4% during the forecast period. The ceramic biomaterial market constitutes 25% of the overall biomaterial market.
The report on the ceramics biomaterials market in Asia analyzes the market in terms of products, namely, aluminum oxide, zirconia, calcium phosphate, calcium sulfate, carbon, and glass. Ceramics are used in dental parts, coatings, bone fillings, endoscopy, ontological implants, medical tools and equipment, drug delivery, and cardiovascular applications, thus boosting the growth of this market. Ceramics biomaterials are also used in maxillofacial surgery as dental material. All of these segments experienced a positive growth until 2012 with an increased awareness of procedures and sophisticated diagnostic techniques. In 2012, the cardiovascular application accounted for 34.5%, followed by orthopedics, which accounted for 34.2% of the total market. Plastic surgery and wound healing application areas are estimated to grow at CAGRs of 18.5% and 17.8%, respectively.
The Asian ceramic biomaterial market was dominated by India and China in 2012 due to increased investments, funding and grants by government institutions, rise in the number of collaborations, conferences and research-related activities, technological advancements, increasing applications of biomaterials, and the aging population. A large amount of research has also been taking place in China, significantly driving the growth of the market in the country, as per the Chinese Society for Biomaterials. The Ninth World Biomaterial Congress, which was held in China in June 2012, discussed the usage of biomaterials in tissue engineering, regenerative medicine, and surface characterization of biomaterials.
The report on the Asian ceramic biomaterial market provides an extensive competitive landscape of companies operating in this market. Major players in covered in the report are Dentsply International, Inc. (U.S.), Wright Medical Group, Inc. (U.S.), DePuy Orthopaedics, Inc. (U.S.), Invibio Ltd. (U.K.), Osteotech, Inc. (U.S.), Biomet, Inc. (U.S.), Berkeley Advanced Biomaterials, Inc. (U.S.), Orthovita, Inc. (U.S.), and others. The key raw material suppliers are Carpenter Technology Corporation (U.S.), Materion Corporation (U.S.), Ulbrich Stainless Steel & Special Metals, Inc. (U.S.), Heraeus Medical Components, CeramTec (a subsidiary of Rockwood Holdings Inc.), (Germany), Ceradyne, Inc. (U.S.), Kyocera Corporation (Japan), Bayer (Germany), Purac Biomaterials (Netherlands), DSM Biomedical, Inc. (U.S.), Evonik Industries (Germany), Cam Bioceramics (Netherlands), Ticona GmbH (Germany), and Landec Corporation (U.S.). The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have been covered in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in keeping with your company’s specific needs. Customize your report on the Asian market for ceramic biomaterials to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of knee, hand, hip, spine osteoarthritis (OA) and rheumatoid arthritis (RA), heart attack, stroke, and ischemia
- Country-specific incidence of knee, hand, hip, spine OA and RA, heart attack, stroke, and ischemia
- Country-specific patient pool of knee, hand, hip, spine OA and RA, heart attack, stroke, and ischemia
- Mortality rate of heart failure, stroke, and ischemia
- Disease progression (pattern analysis)
Procedure Volume Data
- Bilateral and unilateral hip and knee procedures performed annually in each country tracked till sub-segment level
- Number of foot and ankle, wrist, shoulder, elbow, digit, and disc replacement procedures performed in each country
- Number of heart surgeries performed in each country
- Number of maxillofacial and jaw surgeries performed in each country
Surgeon’s/Physician’s Forum
- Fast turnaround analysis of surgeons’ response to market events and trends
- Pattern analysis of usage of ceramic biomaterials by physicians
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of ceramic biomaterials in the Asian market
- Procedural investment in hip and knee, heart surgeries, maxillofacial, and jaw surgeries in the Asian market
Competitive Intelligence
- Company share analysis of top players in the ceramic biomaterial market in the Asian region
- Crucial developments and strategies of companies inculcating ceramic biomaterials in their portfolio
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
North American Biomaterials Market The report “The North American Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The North American Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming | |
European Biomaterials Market The report “The European Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The European Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming | |
Asian Biomaterials Market The report “The Asian Biomaterials market forecast 2012-2014” analyzes the market by technology devices into 4 segments such as Metals, Ceramics, Polymers and Natural Biomaterial. Some of the key players in The Asian Biomaterials market include Medtronic, Inc., Biomet, Inc., Stryker Corporation, Synthes, Inc. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |